Civitas Therapeutics is a biopharmaceutical company focused on developing inhaled therapies for neurological diseases, particularly Parkinson's disease, using its proprietary ARCUS dry powder delivery platform
Civitas Therapeutics is a biopharmaceutical company focused on developing inhaled therapies for neurological diseases, particularly Parkinson's disease, using its proprietary ARCUS dry powder delivery platform.